What the numbers on an insulin syringe mean
An insulin syringe has two numbers that matter and one that confuses people.
The capacity is printed as millilitres: 0.3 mL, 0.5 mL or 1 mL. That is how much liquid the barrel holds.
The scale is printed in units. On a U-100 syringe, 100 units equals 1 mL, so the unit scale is a volume scale with a different name: 1 unit is 0.01 mL, 10 units is 0.1 mL, 50 units is 0.5 mL. A 0.3 mL syringe therefore reads to 30 units, a 0.5 mL to 50 and a 1 mL to 100.
"U-100" is the part that confuses. It does not describe the syringe's contents. It describes the insulin concentration the scale was designed for: 100 units of insulin per millilitre. For anything other than U-100 insulin, the units on the barrel are just hundredths of a millilitre, and how much drug they contain depends entirely on the concentration in the vial.
That last point is the whole reason peptide users need a calculator. A 10 mg vial mixed with 2 mL of water is 5 mg/mL, so each unit on a U-100 syringe holds 50 mcg. The same vial mixed with 4 mL is 2.5 mg/mL, and each unit holds 25 mcg. The syringe has not changed; the meaning of a unit has. The reconstitution calculator and the units chart do that arithmetic.
The three sizes compared
| Syringe | Holds | Scale reads to | Typical markings | Where it suits |
|---|---|---|---|---|
| 0.3 mL | 0.3 mL | 30 units | Every unit; half-unit versions exist | Small volumes where precision matters most |
| 0.5 mL | 0.5 mL | 50 units | Every unit | The middle ground; most reconstituted peptide draws |
| 1 mL | 1 mL | 100 units | Usually every 2 units | Larger volumes, or drawing water to reconstitute |
The trade-off is precision against capacity. The same 0.1 mL occupies a third of a 0.3 mL barrel and a tenth of a 1 mL barrel, so the small syringe spreads it over more distance and finer marks. That is why the peptide calculators on this site warn when a draw comes to fewer than 2 units: on a 1 mL syringe with 2-unit graduations, 2 units is a single mark. If a calculation keeps landing there, the fix is to reconstitute with more water so the same amount of peptide occupies more units, not to squint harder.
Going the other way, a draw that exceeds the barrel is the other failure. The calculators flag that too, and the fix is less water or a larger syringe.
Needle gauge and length
Insulin syringes come with the needle fixed in place, described by two numbers.
Gauge (G) is the needle's thickness, and the scale runs backwards: a higher number is a thinner needle. Insulin syringe needles cluster in the high 20s to low 30s.
Length is in millimetres or fractions of an inch. The 2016 FITTER recommendations, produced by 183 diabetes specialists from 54 countries, are the most cited guidance on this. Their position is that the shortest needles, at that time the 4 mm pen needle and the 6 mm syringe needle, are safe, effective and less painful, and should be the first-line choice in every patient category. The logic is anatomical: a short needle reaches the fat layer without passing into muscle.
That matters because the same recommendations say intramuscular injection should be avoided with subcutaneous drugs, particularly long-acting ones, since muscle absorbs faster and less predictably. The subcutaneous vs intramuscular page covers why the two layers behave differently.
Approved peptide medicines do not use these syringes
Worth knowing: the approved peptide medicines on this site come in devices, not vials. Wegovy is a prefilled, single-dose pen with an integrated needle, supplied four to a carton and discarded after each use, according to its label. Mounjaro, Ozempic, Saxenda and Victoza are also pens. The insulin syringe is the tool of the research-peptide market, where the product is a lyophilised powder that the user reconstitutes and draws. That is one reason the two worlds have such different error profiles: a pen delivers a labelled dose by design, while a syringe delivers whatever the user calculated. Prescribing of the approved medicines belongs with a licensed Philippine physician.
Single use, site rotation and disposal
Three points from the injection technique literature apply to any subcutaneous injection, prescription or otherwise.
Single use. The US CDC's injection safety guidance is unambiguous: once a syringe and needle have been used, both are contaminated and must be discarded. The FITTER paper adds the practical reasons: a reused needle is blunted, which hurts more and damages tissue, and the sterility that protects the injection site is gone. A multi-dose vial is a different object from a syringe. Bacteriostatic water, for instance, contains 0.9% benzyl alcohol as a preservative precisely so a vial can be entered more than once with a fresh sterile needle each time, and the CDC cites USP guidance that an opened multi-dose vial should be dated and discarded within 28 days unless the manufacturer says otherwise.
Rotation. FITTER identifies lipohypertrophy, a rubbery build-up of fat under repeatedly used sites, as a frequent complication that distorts absorption. Injecting into it makes the dose unpredictable; rotating sites prevents it. The side effect management page covers what a normal injection-site reaction looks like against one that needs a doctor.
Sharps. Used needles in household rubbish are a risk of blood-borne infection to whoever handles the bag. FITTER's recommendation is a proper sharps container and a disposal route. In the Philippines, a rigid puncture-proof container with a lid is the minimum, and some hospitals and clinics accept filled containers.
Reading a vial before choosing a syringe
The syringe is the last decision, not the first. It follows from the vial's stated milligrams, the volume of water added, and the amount being drawn. A vial label that is unclear on the first of those makes the rest guesswork; how to read a peptide vial label covers what a label should and should not tell you. For where these syringes fit alongside the compounds people draw with them, see BPC-157, ipamorelin and the GLP-1 pages for semaglutide and tirzepatide.
